153 related articles for article (PubMed ID: 18395138)
21. The management and treatment of children with Fabry disease: A United States-based perspective.
Hopkin RJ; Jefferies JL; Laney DA; Lawson VH; Mauer M; Taylor MR; Wilcox WR;
Mol Genet Metab; 2016 Feb; 117(2):104-13. PubMed ID: 26546059
[TBL] [Abstract][Full Text] [Related]
22. Peripheral nervous system involvement in Fabry disease: role in morbidity and mortality.
Hilz MJ
Clin Ther; 2007; 29 Suppl A():S11-2. PubMed ID: 17580234
[No Abstract] [Full Text] [Related]
23. Cardiac involvement in Fabry's disease.
Nicholls K
Heart Lung Circ; 2005; 14 Suppl 2():S18-20. PubMed ID: 16352280
[TBL] [Abstract][Full Text] [Related]
24. [Fatal outcome of a patient with Fabry disease in enzymatic treatment].
Moyano MJ; del Toro N; Amor J; Milán JA
Nefrologia; 2005; 25(2):207-8. PubMed ID: 15912661
[No Abstract] [Full Text] [Related]
25. Fabry disease--a primer for cardiologists.
Mursă A; Ginghină C; Jurcut R
Rom J Intern Med; 2014; 52(4):216-22. PubMed ID: 25726623
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis of Fabry disease: usefulness of the clinical investigation].
Demontis R
Rev Med Interne; 2010 Dec; 31 Suppl 2():S229-32. PubMed ID: 21211670
[TBL] [Abstract][Full Text] [Related]
27. Renal complications of Fabry disease.
Basic-Jukic N; Kes P; Coric M; Basic-Kes V
Curr Pharm Des; 2013; 19(33):6046-50. PubMed ID: 23448456
[TBL] [Abstract][Full Text] [Related]
28. General Anesthesia and Fabry Disease: A Case Report.
Krüger S; Nowak A; Müller TC
A A Case Rep; 2017 May; 8(10):247-249. PubMed ID: 28079663
[TBL] [Abstract][Full Text] [Related]
29. Rare diseases in Croatia--lesson learned from Anderson-Fabry disease.
Mrsić M; Nola M
Croat Med J; 2008 Oct; 49(5):579-81. PubMed ID: 18925690
[No Abstract] [Full Text] [Related]
30. Beneficial effects of long-term enzyme replacement therapy in a child with Fabry disease.
Martin-Suárez I; Suárez-Marrero C
Int J Clin Pract; 2010 Jun; 64(7):995. PubMed ID: 20584233
[No Abstract] [Full Text] [Related]
31. Cutaneous complications of Anderson-Fabry disease.
Giuseppe P; Daniele R; Rita BM
Curr Pharm Des; 2013; 19(33):6031-6. PubMed ID: 23448454
[TBL] [Abstract][Full Text] [Related]
32. Fabry disease: is there a role for enzyme replacement therapy?
Mehta AB
J Intern Med; 2013 Oct; 274(4):329-30. PubMed ID: 23662843
[No Abstract] [Full Text] [Related]
33. Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study.
Mignani R; Panichi V; Giudicissi A; Taccola D; Boscaro F; Feletti C; Moneti G; Cagnoli L
Kidney Int; 2004 Apr; 65(4):1381-5. PubMed ID: 15086478
[TBL] [Abstract][Full Text] [Related]
34. Enzyme replacement in Fabry disease: the essence is in the kidney.
Schiffmann R
Ann Intern Med; 2007 Jan; 146(2):142-4. PubMed ID: 17179053
[No Abstract] [Full Text] [Related]
35. Enzyme replacement in Anderson-Fabry disease.
Bengtsson BA; Johansson JO; Hollak C; Linthorst G; FeldtRasmussen U
Lancet; 2003 Jan; 361(9354):352. PubMed ID: 12559898
[No Abstract] [Full Text] [Related]
36. Fabry disease: clinical outcomes of agalsidase enzyme replacement therapies.
Wanner C
Int J Clin Pract; 2007 Jul; 61(7):1234-5; author reply 1235. PubMed ID: 17577304
[No Abstract] [Full Text] [Related]
37. [Fabry's disease revealed by stroke: a case report].
Ronzière T
Rev Med Interne; 2010 Dec; 31 Suppl 2():S260-2. PubMed ID: 21211676
[TBL] [Abstract][Full Text] [Related]
38. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.
Eng CM; Germain DP; Banikazemi M; Warnock DG; Wanner C; Hopkin RJ; Bultas J; Lee P; Sims K; Brodie SE; Pastores GM; Strotmann JM; Wilcox WR
Genet Med; 2006 Sep; 8(9):539-48. PubMed ID: 16980809
[TBL] [Abstract][Full Text] [Related]
39. Kidney transplantation and enzyme replacement therapy in patients with Fabry disease.
Cybulla M; Kurschat C; West M; Nicholls K; Torras J; Sunder-Plassmann G; Feriozzi S
J Nephrol; 2013; 26(4):645-51. PubMed ID: 23023720
[TBL] [Abstract][Full Text] [Related]
40. Enzyme replacement therapy in Fabry disease: comparison of agalsidase alfa and agalsidase beta.
Mehta A; Beck M; Kampmann C; Frustaci A; Germain DP; Pastores GM; Sunder-Plassmann G
Mol Genet Metab; 2008; 95(1-2):114-5. PubMed ID: 18701330
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
